FWL Investment Management’s Edwards Lifesciences EW Stock Holding History

FWL Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.8K	Hold	440	–	–	0.01%	223
2026 Q1	$35.2K	Hold	440	–	–	0.01%	188
2025 Q4	$37.5K	Hold	440	–	–	0.01%	183
2025 Q3	$34.2K	Hold	440	–	–	0.01%	169
2025 Q2	$34.4K	Hold	440	–	–	0.01%	170
2025 Q1	$31.9K	Hold	440	–	–	0.01%	163
2024 Q4	$32.6K	Sell	440 -100	-19%	-$7K	0.01%	173
2024 Q3	$35.6K	Hold	540	–	–	0.01%	145
2024 Q2	$49.9K	Hold	540	–	–	0.03%	108
2024 Q1	$51.6K	Hold	540	–	–	0.03%	93
2023 Q4	$41.2K	Hold	540	–	–	0.02%	101
2023 Q3	$37.4K	Buy	+540	New	+$43.4K	0.03%	106
2023 Q1	–	Sell	-1,755	Closed	-$131K	–	107
2022 Q4	$131K	Buy	+1,755	New	+$135K	0.1%	58

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

FWL Investment Management's EW Position: Q2 2026 in Review

FWL Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 440 shares worth $39.8K. The position accounts for 0.01% of the portfolio, ranked #223.

FWL Investment Management first reported a position in EW in Q4 2022 and has held it in 13 quarters since. The position peaked at $131K in Q4 2022. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

FWL Investment Management held 440 shares of Edwards Lifesciences worth $39.8K as of Q2 2026.
FWL Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.01% of FWL Investment Management's portfolio in Q2 2026, its #223 holding.
FWL Investment Management first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 13 quarters since.
FWL Investment Management's Edwards Lifesciences position peaked at $131K in Q4 2022.
1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.